New Delhi: Zydus Lifesciences Ltd on Friday announced a partnership with Apollo Hospitals to offer Shield multi-cancer detection test to patients in India.
Through its exclusive agreement with Guardant Health, Inc, a leading precision oncology company, Zydus Lifesciences has the rights to make the Shield multi-cancer detection (MCD) test available in India.